SEC Form 4 research
| Issuer | Monopar Therapeutics |
|---|---|
| Tickers | MNPR |
| Reporting owners | 23 |
| Officers and directors | 9 |
| Last public filing | 2026-11-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-11-02 | Anderson Raymond | S | 1,502 | $70.04 | Not reported |
| 2026-11-04 | 2026-11-02 | Anderson Raymond | S | 200 | $68.68 | Not reported |
| 2026-11-04 | 2026-11-02 | Anderson Raymond | S | 600 | $67.06 | Not reported |
| 2026-11-04 | 2026-11-02 | Anderson Raymond | S | 840 | $66.16 | Not reported |
| 2026-11-04 | 2026-11-04 | Tsuchimoto Kim R | S | 600 | $72.21 | Not reported |
| 2026-11-04 | 2026-11-04 | Tsuchimoto Kim R | S | 996 | $71.35 | Not reported |
| 2026-11-04 | 2026-11-04 | Tsuchimoto Kim R | S | 1,295 | $70.75 | Not reported |
| 2026-11-04 | 2026-11-02 | Tsuchimoto Kim R | S | 1,199 | $70.1 | Not reported |
| 2026-10-05 | 2026-10-01 | STARR CHRISTOPHER M | S | 799 | $79.67 | Not reported |
| 2026-10-05 | 2026-10-01 | STARR CHRISTOPHER M | S | 2,970 | $78.82 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.